Separate names with a comma.
Great News out , if this Drug also works in Phase 3 (results expected next year) then this one will be the next Billion Dollar Company ,this...
Analysts Offer Insights on Healthcare Companies: Soleno Therapeutics Inc (NASDAQ: SLNO) and Alexion Pharmaceuticals (NASDAQ: ALXN)...
Great News out stock exploding in pre market .. Soleno Therapeutics Announces Issuance Of New U.S. Patent For DCCR In Treatment Of Prader-Willi...
Once we break the MA (200) at 0.69 then $1+ coming quickly . [IMG]
Soleno (SLNO) is a new formed company through the merger between Capnia and the private Essentials (merger completed in march 2017) thats why its...
New Fact Sheet .... http://files.shareholder.com/downloads/OCLS/4978439479x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf Ø...
They got another FDA approval for a new Product 2 weeks ago for which there was no press release because of competitive reasons , and many more...
This undiscovered Stock is one of the most attractive that i ever recommended . Valuation is only 22 Million they have $12.6 million in Cash and...
Positive Phase 3 Results --- AcelRx Pharmaceuticals Reports Successful Outcome of ZALVISO Phase 3 IAP312 Study on Device Functionality...
All stocks i recommend here on stockaholics are based on my own research and im a shareholder of these stocks i never got even a single penny from...
Can you believe that this low float stock has a terrible low valuation of just $21 million which is very close to the cash balance of $17 million...
Hit $2 today and market cap is still very low with $22 milion which is close to cash balance of $17 million
it could hit $2+ quickly if it breaks the MA(50) at $1.70 [IMG]
An older article but nice one which shows the massive potential here...
Market cap unbelievable $17 million which is same as current cash balance of $17 million , Shares out 10.6 M even if this stock moves 1000% the...
Another very hot and heavily undervalued FDA Gem ... KTOV (MC $16 M) (Cash $17 M) US-NDA Submission for their osteoarthritis pain and...
ACRX Gains On Coming Catalyst As mentioned above, AcelRx is having an incredibly strong day in the market today, and for good reason. A report...
Nice jump in Pre-Mkt and we are just days away before phase 3 results will be released and 3 months before FDA decision so there is good chance...
In a research report issued Friday, Jefferies analyst Matthew Andrews assumed coverage on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), with...
Very attractive and dirt cheap FDA Play ..... ACRX has 2 Products including potential Blockbuster under review by FDA and MAA (Europe) . Upcoming...
